Paper40501468
Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury.
Ramírez-Mejía MM and 2 others. World J Hepatol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury. Papers, record 40501468. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40501468
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Open questions on how metabolic dysfunction-associated steatotic liver disease shapes the course of drug-induced liver injury.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21349301 | Causality assessment methods in drug induced liver injury: strengths and weaknesses. | J Hepatol | 2011 | https://conductscience.org/library/papers/21349301 | PubMed |
| 2 | 40027577 | Clinical features and prognosis of drug-induced liver injury in patients with non-alcoholic fatty liver. | World J Hepatol | 2025 | https://conductscience.org/library/papers/40027577 | PubMed |
| 3 | 8229110 | Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. | J Clin Epidemiol | 1993 | https://conductscience.org/library/papers/8229110 | PubMed |
| 4 | 38049180 | Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | J Obes Metab Syndr | 2023 | https://conductscience.org/library/papers/38049180 | PubMed |
| 5 | 31417407 | Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31417407 | PubMed |
| 6 | 36569882 | Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis. | Front Immunol | 2022 | https://conductscience.org/library/papers/36569882 | PubMed |
| 7 | 8229111 | Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. | J Clin Epidemiol | 1993 | https://conductscience.org/library/papers/8229111 | PubMed |
| 8 | 38287834 | Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. | Front Biosci (Landmark Ed) | 2024 | https://conductscience.org/library/papers/38287834 | PubMed |
| 9 | 33003400 | Worldwide Use of RUCAM for Causality Assessment in 81,856 Idiosyncratic DILI and 14,029 HILI Cases Published 1993-Mid 2020: A Comprehensive Analysis. | Medicines (Basel) | 2020 | https://conductscience.org/library/papers/33003400 | PubMed |
| 10 | 39166347 | Methods for causality assessment of idiosyncratic drug-induced liver injury. | Liver Int | 2025 | https://conductscience.org/library/papers/39166347 | PubMed |
| 11 | 28405790 | CSH guidelines for the diagnosis and treatment of drug-induced liver injury. | Hepatol Int | 2017 | https://conductscience.org/library/papers/28405790 | PubMed |
| 12 | 36968618 | Drug-induced liver injury: a comprehensive review. | Ther Adv Gastroenterol | 2023 | https://conductscience.org/library/papers/36968618 | PubMed |
| 13 | 35603224 | Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. | Front Immunol | 2022 | https://conductscience.org/library/papers/35603224 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40501468
GET https://conductscience.org/api/papers/v1/40501468/authors